High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection

A. Wadhwa, M. F. Al Nahhas, R. A. Dierkhising, Robin Patel, Purna C Kashyap, D. S. Pardi, S. Khanna, Madhusudan Grover

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: Infectious enteritis is a commonly identified risk factor for irritable bowel syndrome (IBS). The incidence of Clostridium difficile infection (CDI) is on the rise. However, there is limited information on post-infectious IBS (PI-IBS) development following CDI and the host- and infection-related risk factors are not known. Aim: To determine the incidence and risk factors for PI-IBS following CDI. Methods: A total of 684 cases of CDI identified from September 2012 to November 2013 were surveyed. Participants completed the Rome III IBS questionnaire and details on the CDI episode. Predictive modelling was done using logistic regression to evaluate risk factors for PI-IBS development. Results: A total of 315 CDI cases responded (46% response rate) and 205 were at-risk (no pre-CDI IBS) for PI-IBS development. A total of 52/205 (25%) met the Rome III criteria for IBS ≥6 months following CDI. IBS-mixed was most common followed by IBS-diarrhoea. In comparison to those without subsequent PI-IBS, greater percentage of PI-IBS patients had CDI symptoms >7 days, nausea, vomiting, abdominal pain during CDI, anxiety and a higher BMI. Using logistic regression, CDI symptoms >7 days [Odds ratio (OR): 2.96, P = 0.01], current anxiety (OR: 1.33, P < 0.0001) and a higher BMI (OR: 1.08, P = 0.004) were independently associated with PI-IBS development; blood in the stool during CDI was protective (OR: 0.44, P = 0.06). Conclusions: In this cohort study, new-onset IBS is common after CDI. Longer CDI duration, current anxiety and higher BMI are associated with the diagnosis of C. difficile PI-IBS. This chronic sequela should be considered during active management and follow-up of patients with CDI.

Original languageEnglish (US)
Pages (from-to)576-582
Number of pages7
JournalAlimentary Pharmacology and Therapeutics
Volume44
Issue number6
DOIs
StatePublished - Sep 1 2016

Fingerprint

Clostridium Infections
Clostridium difficile
Irritable Bowel Syndrome
Odds Ratio
Anxiety
Logistic Models
Enteritis
Incidence

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. / Wadhwa, A.; Al Nahhas, M. F.; Dierkhising, R. A.; Patel, Robin; Kashyap, Purna C; Pardi, D. S.; Khanna, S.; Grover, Madhusudan.

In: Alimentary Pharmacology and Therapeutics, Vol. 44, No. 6, 01.09.2016, p. 576-582.

Research output: Contribution to journalArticle

@article{06c876e00f2148c4a878efaf08bccc57,
title = "High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection",
abstract = "Background: Infectious enteritis is a commonly identified risk factor for irritable bowel syndrome (IBS). The incidence of Clostridium difficile infection (CDI) is on the rise. However, there is limited information on post-infectious IBS (PI-IBS) development following CDI and the host- and infection-related risk factors are not known. Aim: To determine the incidence and risk factors for PI-IBS following CDI. Methods: A total of 684 cases of CDI identified from September 2012 to November 2013 were surveyed. Participants completed the Rome III IBS questionnaire and details on the CDI episode. Predictive modelling was done using logistic regression to evaluate risk factors for PI-IBS development. Results: A total of 315 CDI cases responded (46{\%} response rate) and 205 were at-risk (no pre-CDI IBS) for PI-IBS development. A total of 52/205 (25{\%}) met the Rome III criteria for IBS ≥6 months following CDI. IBS-mixed was most common followed by IBS-diarrhoea. In comparison to those without subsequent PI-IBS, greater percentage of PI-IBS patients had CDI symptoms >7 days, nausea, vomiting, abdominal pain during CDI, anxiety and a higher BMI. Using logistic regression, CDI symptoms >7 days [Odds ratio (OR): 2.96, P = 0.01], current anxiety (OR: 1.33, P < 0.0001) and a higher BMI (OR: 1.08, P = 0.004) were independently associated with PI-IBS development; blood in the stool during CDI was protective (OR: 0.44, P = 0.06). Conclusions: In this cohort study, new-onset IBS is common after CDI. Longer CDI duration, current anxiety and higher BMI are associated with the diagnosis of C. difficile PI-IBS. This chronic sequela should be considered during active management and follow-up of patients with CDI.",
author = "A. Wadhwa and {Al Nahhas}, {M. F.} and Dierkhising, {R. A.} and Robin Patel and Kashyap, {Purna C} and Pardi, {D. S.} and S. Khanna and Madhusudan Grover",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/apt.13737",
language = "English (US)",
volume = "44",
pages = "576--582",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection

AU - Wadhwa, A.

AU - Al Nahhas, M. F.

AU - Dierkhising, R. A.

AU - Patel, Robin

AU - Kashyap, Purna C

AU - Pardi, D. S.

AU - Khanna, S.

AU - Grover, Madhusudan

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Background: Infectious enteritis is a commonly identified risk factor for irritable bowel syndrome (IBS). The incidence of Clostridium difficile infection (CDI) is on the rise. However, there is limited information on post-infectious IBS (PI-IBS) development following CDI and the host- and infection-related risk factors are not known. Aim: To determine the incidence and risk factors for PI-IBS following CDI. Methods: A total of 684 cases of CDI identified from September 2012 to November 2013 were surveyed. Participants completed the Rome III IBS questionnaire and details on the CDI episode. Predictive modelling was done using logistic regression to evaluate risk factors for PI-IBS development. Results: A total of 315 CDI cases responded (46% response rate) and 205 were at-risk (no pre-CDI IBS) for PI-IBS development. A total of 52/205 (25%) met the Rome III criteria for IBS ≥6 months following CDI. IBS-mixed was most common followed by IBS-diarrhoea. In comparison to those without subsequent PI-IBS, greater percentage of PI-IBS patients had CDI symptoms >7 days, nausea, vomiting, abdominal pain during CDI, anxiety and a higher BMI. Using logistic regression, CDI symptoms >7 days [Odds ratio (OR): 2.96, P = 0.01], current anxiety (OR: 1.33, P < 0.0001) and a higher BMI (OR: 1.08, P = 0.004) were independently associated with PI-IBS development; blood in the stool during CDI was protective (OR: 0.44, P = 0.06). Conclusions: In this cohort study, new-onset IBS is common after CDI. Longer CDI duration, current anxiety and higher BMI are associated with the diagnosis of C. difficile PI-IBS. This chronic sequela should be considered during active management and follow-up of patients with CDI.

AB - Background: Infectious enteritis is a commonly identified risk factor for irritable bowel syndrome (IBS). The incidence of Clostridium difficile infection (CDI) is on the rise. However, there is limited information on post-infectious IBS (PI-IBS) development following CDI and the host- and infection-related risk factors are not known. Aim: To determine the incidence and risk factors for PI-IBS following CDI. Methods: A total of 684 cases of CDI identified from September 2012 to November 2013 were surveyed. Participants completed the Rome III IBS questionnaire and details on the CDI episode. Predictive modelling was done using logistic regression to evaluate risk factors for PI-IBS development. Results: A total of 315 CDI cases responded (46% response rate) and 205 were at-risk (no pre-CDI IBS) for PI-IBS development. A total of 52/205 (25%) met the Rome III criteria for IBS ≥6 months following CDI. IBS-mixed was most common followed by IBS-diarrhoea. In comparison to those without subsequent PI-IBS, greater percentage of PI-IBS patients had CDI symptoms >7 days, nausea, vomiting, abdominal pain during CDI, anxiety and a higher BMI. Using logistic regression, CDI symptoms >7 days [Odds ratio (OR): 2.96, P = 0.01], current anxiety (OR: 1.33, P < 0.0001) and a higher BMI (OR: 1.08, P = 0.004) were independently associated with PI-IBS development; blood in the stool during CDI was protective (OR: 0.44, P = 0.06). Conclusions: In this cohort study, new-onset IBS is common after CDI. Longer CDI duration, current anxiety and higher BMI are associated with the diagnosis of C. difficile PI-IBS. This chronic sequela should be considered during active management and follow-up of patients with CDI.

UR - http://www.scopus.com/inward/record.url?scp=84981250026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981250026&partnerID=8YFLogxK

U2 - 10.1111/apt.13737

DO - 10.1111/apt.13737

M3 - Article

C2 - 27444134

AN - SCOPUS:84981250026

VL - 44

SP - 576

EP - 582

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 6

ER -